Tilgen eds (2 resultados)
Idioma: Inglés
Editorial: Springer, Berlin / New York. 2001
Serie: Recent Results in Cancer Research, Libro 101 de 157. Libro 101 de 157 - Recent Results in Cancer Research
- Tapa dura
Librería: Tiber Books, Cockeysville, MD, Estados Unidos de AmericaTiber Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Usado - Aceptable
EUR 39,04
Envío por EUR 4,73Se envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: Good. 8vo, hardcover. No dj, as issued. Good condition. Non-circulating ex-lib copy w/ label inside cover, exterior labels neatly removed (only markings). Contents bright & clean, binding tight. xii, 268 p., illus. Proceedings from the 1st International Symposium on Minimal Residual Disease in Melanoma, hel…d in September 1999 in Homburg/Saar, Germany.
Idioma: Inglés
Editorial: Springer Verlag 2000
Serie: Recent Results in Cancer Research, Libro 101 de 157. Libro 101 de 157 - Recent Results in Cancer Research
- Tapa dura
Librería: CSG Onlinebuch GMBH, Darmstadt, , AlemaniaCSG Onlinebuch GMBH
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Bueno
EUR 16,92
Envío por EUR 95,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Gebunden. Condición: Gut. Gebraucht - Gut Zustand: Gut, XII, 268 pp. 40 figs., 45 tabs. About this book: This volume comprises the proceedings of the First International Symposium on Minimal Residual Disease in Melanoma, held in Homburg/Saar, Germany in September 1999. Containing contributions by 24 renowned experts, the book co…vers all aspects of diagnosis and treatment of micrometastatic disease in melanoma. The topics include: biology of micrometastases and advanced methods for detection; detection of residual melanoma cells in the peripheral blood and bone marrow; detection of minimal residual disease in sentinel nodes; early recognition and monitoring by serological markers; clinical relevance of micrometastasis detection; therapeutic strategies to deal with residual melanoma cells. Written for clinicians, scientists.
